VINBLASTINE SULFATE INJECTION DIN 02406675
Health Canada record
| Active ingredient(s) | VINBLASTINE SULFATE 1 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01CA01 VINBLASTINE |
| Original market date | |
| Current status date | 01-Aug-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VINBLASTINE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02183056 | VINBLASTINE SULFATE INJECTION | PFIZER CANADA ULC | Solution | VINBLASTINE SULFATE 1 MG | Marketed |
| 02401460 | VINBLASTINE SULPHATE INJECTION | TEVA CANADA LIMITED | Solution | VINBLASTINE SULFATE 1 MG | Marketed |
| 00015431 | VELBE 1MG/ML | ELI LILLY CANADA INC | Powder For Solution | VINBLASTINE SULFATE 10 MG | Cancelled Post Market |
| 01977784 | VINBLASTINE SULFATE INJ 1MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | VINBLASTINE SULFATE 1 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14382 | 2013-05-22 | Abbreviated New Drug Submission (ANDS) |
International API supply for VINBLASTINE SULFATE
2 valid EDQM Certificates of Suitability from 2 holders. 3 active FDA Drug Master Files.
Request a quote for VINBLASTINE SULFATE INJECTION